Drug Side Effects
Search
AUTOIMMUNE CHOLANGITIS
AUTOIMMUNE CHOLANGITIS
was reported 44 times
AUTOIMMUNE CHOLANGITIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Programmed Death Receptor-1 Blocking Antibody [EPC]
29
0.0003
1
CTLA-4-directed Blocking Antibody [EPC]
6
0.0001
2
Programmed Death Ligand-1 Blocker [EPC]
2
0.0001
3
Lipid-based Polyene Antifungal [EPC]
1
0.0001
4
Microtubule Inhibitor [EPC]
12
0.0001
5
Platinum-based Drug [EPC]
15
0.0001
6
Bile Acid [EPC]
1
0.0000
7
Integrin Receptor Antagonist [EPC]
3
0.0000
8
Provitamin D2 Compound [EPC]
1
0.0000
9
Topoisomerase Inhibitor [EPC]
2
0.0000
10
Polyene Antifungal [EPC]
1
0.0000
11
Thiazide-like Diuretic [EPC]
1
0.0000
12
Purine Antimetabolite [EPC]
1
0.0000
13
Aminosalicylate [EPC]
1
0.0000
14
Dihydropyridine Calcium Channel Blocker [EPC]
3
0.0000
15
Aromatase Inhibitor [EPC]
1
0.0000
16
Factor Xa Inhibitor [EPC]
2
0.0000
17
Azole Antifungal [EPC]
1
0.0000
18
Proton Pump Inhibitor [EPC]
3
0.0000
19
Tumor Necrosis Factor Blocker [EPC]
5
0.0000
20
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
21
Corticosteroid [EPC]
5
0.0000
22
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
23
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
25
GLP-1 Receptor Agonist [EPC]
1
0.0000
26
Insulin Analog [EPC]
1
0.0000
27
Kinase Inhibitor [EPC]
1
0.0000
28
Platelet Aggregation Inhibitor [EPC]
1
0.0000
29
Benzodiazepine [EPC]
1
0.0000